GE releases low-dose CT technology

GE Healthcare’s Veo, a low-dose CT technology, recently received FDA 510(k) clearance and is now available in the U.S. The CT technology utilizes model-based iterative reconstruction, and is available on GE Discovery CT750 HD systems in Europe, Canada and parts of Asia.

Users in Europesaid that the chest CTs done with a Veo produce the same amount of medical radiation dose as a chest x-ray, according to GE. The company is coordinating a multicenter study to investigate new improvements, including substantially lower dose levels.


Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.